KEROS THERAPEUTICS INC
KROS·492327101·US·Common Stock·Healthcare - Biotechnology-Activist
KROS (KEROS THERAPEUTICS INC) is held by 91 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($26.6M), VANGUARD CAPITAL MANAGEMENT LLC ($9.2M), Qube Research & Technologies Ltd ($8M). Net institutional sentiment: Mixed.
91
Holders
Avg rating(21 Elite)
$161.5M
Total Value
49% (100)
Fund Consensus
46 buying - 48 selling
Who's Trading
InsiderNWNewton Charles W.Sell $6KJun 11, 2026
InsiderKJKnowles JuliusSell $28KJun 4, 2026
InsiderFNFarzan NimaSell $28KJun 4, 2026
InsiderSASeth AlpnaSell $28KJun 4, 2026
ActivistNANantahala Capital Management, LLC6.9%May 15, 2026
InsiderBJBIENAIME JEAN JACQUESBuy $12KApr 15, 2026
InsiderBJBIENAIME JEAN JACQUESBuy $22KMar 9, 2026
InsiderSJSeehra JasbirSell $113KFeb 19, 2026
13F: Insider & Congress:
Showing 1-20 of 100
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer